Winter & Associates’s Amgen AMGN Stock Holding History

Winter & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$220K	Buy	+502	New	+$200K	0.16%	70

Other funds holding AMGN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Winter & Associates's AMGN Position: Q3 2026 in Review

Winter & Associates opened a new position in Amgen (AMGN) in Q3 2026: 502 shares worth $220K. The stake represents 0.16% of the portfolio and ranks #70 among its holdings.

1,057 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Winter & Associates held 502 shares of Amgen worth $220K as of Q3 2026.
Amgen was a new Winter & Associates position in Q3 2026.
Amgen made up 0.16% of Winter & Associates's portfolio in Q3 2026, its #70 holding.
1,057 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Winter & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.